Angel Medical Systems dba AngelMed has filed a notice of an exempt offering of securities to raise $40,300,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Angel Medical Systems dba AngelMed is raising $40,300,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brad Snow played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Angel Medical Systems dba AngelMed
Angel Medical Systems, Inc. was founded by Drs. Robert, Tim and David Fischell to advance life-sustaining patient care and the long-term management of High-Risk Coronary Artery Disease. The AngelMed Guardian System received approval by the U.S. Food and Drug Administration (FDA) in April 2018. The AngelMed Guardian is an implantable cardiac monitor with patient alerting for patients who have had prior Acute Coronary Syndromes (ACS), including myocardial infarctions (heart attacks) or unstable angina and who remain at high risk for recurrent ACS events including silent heart attacks.
To learn more about Angel Medical Systems dba AngelMed, visit http://www.angel-med.com/
Contact:
Brad Snow, Chief Executive Officer
732-542-5551
https://www.linkedin.com/in/brad-snow-a537623/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.